Hepatitis E Diagnostic Tests Market size was valued at USD 137.48 Million in 2022 and the total Hepatitis E Diagnostic Tests revenue is expected to grow at a CAGR of 3.8% from 2023 to 2029, reaching nearly USD 178.49 Million. According to the MMR analysis, the hepatitis E diagnostic tests market is expected to witness significant growth during the forecast period. The high prevalence rate of hepatitis E is due to factors such as limited access to essential water, lack of sanitation & hygiene, lack of nutritional foods, poor quality foods and poor health services has led to the demand for hepatitis E diagnostic tests across the developing countries. According to the World Health Organization (WHO), approximately 20 million people suffer from Hepatitis E each year, out of which 3.3 million are symptomatic cases and 56 600 hepatitis E-related deaths. In addition, increasing governmental initiatives, rising awareness about hepatitis diseases, increased tourism, and the introduction of novel diagnostic kits by major market players are further expected to be the major growth drivers for the hepatitis E diagnostic tests market. Hepatitis E is a liver inflammation caused by the hepatitis E virus (HEV). The Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis globally. HEV is spread by contaminated food and water. Hepatitis E is recognized as a travel-associated infection. The detection of viral RNA in the serum or feces is used to diagnose HEV. Hepatitis E has no particular therapy. HEV is detected through RNA analysis in biological materials such as feces, serum, and liver biopsy. The most significant ways of hepatitis virus prevention are good personal cleanliness, safe public water supply, efficient sanitary waste disposal, and food safety. According to WHO figures, an estimated 20 people die each year. According to WHO statistics, approximately 20 million people are infected by HEV each year, globally.To know about the Research Methodology :- Request Free Sample Report
Hepatitis E Diagnostic Tests Market Dynamics:
High prevalence of hepatitis E Hepatitis is a significant public health concern with a high prevalence rate globally, despite significant developments in medical interventions, vaccination coverage, and public awareness. Of all the hepatitis types, hepatitis E is the most prevalent and makes a significant contribution toward higher mortality rates. Globally, it is estimated that around 939 million people, or one in every eight, have been infected with HEV. Pigs are the primary reservoir for zoonotic HEV viruses. As a result, the consumption of pork and pork products has led to the risk of hepatitis E in individuals. Thus, the demand for hepatitis E diagnostic Tests has rapidly increased across the world, eventually increasing the hepatitis E diagnostic tests market growth during the forecast period. Globally, the epidemiological characteristics and clinical burden of HEV infection in the human population vary between countries/regions. It is fascinating to postulate whether this is associated with the specific prevalence rate of HEV in the local swine population and available pork products. HEV prevalence in farmed pigs varies significantly by country, ranging from 9.90% (Thailand, 95% CI 8.01-11.96) to 84.02% (India, 95% CI 44.05-100.00, I2 = 99%) of anti-HEV seroprevalence and 0% (Croatia, 95% CI 0.00-0.37) to 76.67% (Nigeria, 95% CI 67.32-84.89) of HEV RNA positivity. GT3 is found all over the world, whereas GT4 is mostly found in the Western Pacific region. GT3 and GT4 are interestingly co-circulating in countries/territories such as mainland China, Taiwan, Korea, and Japan. Despite the fact that GT3 HEV predominates in Europe, GT4 HEV has been detected in some unusual cases, including chronically infected people. Additionally, GT3 and GT4 are co-circulating in Belgian domestic pig populations. Lack of regulations for nucleic acid tests in emerging economies Lack of awareness about hepatitis diseases among the population, high cost of diagnostic tests, and inadequate reimbursement regulations are some factors that are expected to restrain the hepatitis E diagnostic tests market growth during the forecast period. In emerging countries, NAT is not mandatory because of the expensive nature of this test and the requirement of skilled personnel. By 2016, only 58 out of a total of 2,550 (2% of) blood banks in India performed NAT for hepatitis E diagnosis. In many developing countries, such as India and China, ELISA remains the only obligatory test, posing a significant barrier to NAT adoption. Blood screening in India includes serological testing for hepatitis surface antigens; however, there are no regulations for the use of NAT. As a result, there is a lack of clarity about findings among persons having hepatitis E diagnostic tests, which is a key limitation for the hepatitis E diagnostic tests market growth. Increasing biotechnology and biopharmaceutical industries The biotechnology and biopharmaceutical industries have a significant demand for immunoassay kits and reagents. As a result, the increase of such industries is expected to accelerate the growth of the hepatitis E diagnostic tests market during the forecast period. The increase in the end-user population in these industries has driven many organizations to introduce new products and investment in creating better-quality products. Because immunoassays are used at numerous phases, from product development and manufacturing to quality control in production, this is regarded as a favorable sign for market growth.Hepatitis E Diagnostic Tests Market Segment Analysis:
Based on the test Kit type, the ELISA HEV IgM Test kits segment dominated the global hepatitis E diagnostic tests market with the highest market share of 32.8% in 2022. The segment is expected to grow at a CAGR of 3.78% during the forecast period and maintain its dominance by 2029. The increased use of HEV-IgM ELISA test kits in clinical laboratories is expected to be the primary growth driver for the segment. In addition, these test kits are rapidly adopted for research and in vitro diagnostic purposes. HEV-IgM is a rapid, self-performing, immunochromatographic assay for the detection of IgM antibodies to the Hepatitis E virus in human serum/plasma. HEV-IgM ELISA is an enzyme-linked immunosorbent test used to detect IgM-class antibodies to the hepatitis E virus in human serum or plasma. It is designed for use in clinical laboratories for the diagnosis and treatment of patients with hepatitis E virus infection. An estimated 20 million HEV infections occur each year, resulting in about three million clinical cases and 70,000 mortality. Infected individuals follow a normal serological pattern, with IgM antibodies initially appearing, followed by IgG seroconversion. The number of IgM antibodies drops fast during the acute phase, and subsequently, more long-lasting IgG antibodies appear for up to 14 years. As a result, the demand for ELISA HEV IgM Test kits has rapidly increased across the end-users.The ELISA HEV IgG Test kits segment is expected to grow at a CAGR of 3.12% during the forecast period. Anti-HEV antigen (Ag)-specific ELISA is now commercially accessible as a low-cost alternative to PCR. HEV IgG Antibody ELISA is a quick and easy method for detecting IgG antibodies to Hepatitis E Virus (HEV) in human serum or plasma. The RT-PCR Test kits segment is expected to grow at a moderate rate during the forecast period. The use of this method of HEV detection is mostly due to its sensitivity and specificity. This method is frequently used for in vitro diagnostic applications, however, it is a somewhat costly method that requires a suite of controls to verify that they have been conducted correctly. As a result, the RT-PCR method's usage is significantly reduced, resulting in a moderate growth rate for the segment.
Hepatitis E Diagnostic Tests Market Regional Insights:
The Asia-Pacific region dominated the global hepatitis E Diagnostic Tests market with the highest revenue share in terms of both value and volume in 2022. The high prevalence rate of various infectious diseases in the region is expected to be the primary factor responsible for Hepatitis. As a result, the demand for diagnostic tests is increased rapidly in the region. The Hepatitis E virus (HEV) is a leading cause of hepatitis, causing considerable morbidity and mortality in developing countries such as Bangladesh. Hepatitis E infection is frequent in low- and middle-income countries, because of insufficient access to the necessary water, lack of sanitation, hygiene, and poor health services, such as in South Asia, and Central and Middle Asia. In these countries, the virus emerges as outbreaks as well as sporadic cases. As a result, the sales of hepatitis E diagnostic Tests are significantly increased, leading to an increase in the revenue share of the market in the region. In addition, the rapidly increasing geriatric population, increasing pork consumption, high adoption of Hepatitis E tests, increasing awareness among the population regarding the diagnosis of hepatitis, and advanced product launches by the market players in the region are some other factors that are expected to boost the hepatitis E diagnostic tests market growth during the forecast period.India is expected to hold the largest market share of 37.8% by 2029. According to the MMR analysis, approximately 60% of blood donors in India have circulating anti-HEV IgG antibodies, indicating past viral exposure, indicating that HEV infection and disease are extremely prevalent in the country. The frequencies of seroprevalence vary by age, with older persons having higher rates. 5 Hepatitis E is responsible for about half of all cases of acute hepatitis and a corresponding number of cases of acute liver failure (ALF). This factor is expected to increase hepatitis diagnostic tests in the country, leading to an increase the market growth. Meanwhile, the majority of India's pigs are situated in the country's central and northern zones. In 2019, Assam had almost two million pigs. Because pigs are regarded to be the primary carrier of HEV, the high pork consumption shows that the illness is spread via zoonotic agents. As a result, it has increased the demand for hepatitis E diagnostic tests and increased the hepatitis E diagnostic Tests market growth in the country.
Hepatitis E Diagnostic Tests Market Scope: Inquiry Before Buying
Hepatitis E Diagnostic Tests Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: USD 137.48 Million. Forecast Period 2023 to 2029 CAGR: 3.8 % Market Size in 2029: USD 178.49 Million. Segments Covered: by Test Kit Type 1. ELISA HEV IgM Test kits 2. ELISA HEV IgG Test kits 3. RT-PCR Test kits 4. Other by End-user 1. Hospitals 2. Research Centers 3. Diagnostic Laboratories 4. Point of Care 5. Other by Test Type 1. Blood Tests 2. Imaging Test 3. Liver Biopsy Hepatitis E Diagnostic Tests Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Hepatitis E Diagnostic Tests Market, Key Players are
1. Chemeurope (EU) 2. Roche Holding AG (Switzerland) 3. Fortress Diagnostics (United Kingdom) 4. Altona Diagnostics GmbH (Germany) 5. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (China) 6. Biokit S.A. (Spain) 7. F. Hoffmann-La Roche Ltd. (Switzerland) 8. Dia.Pro - Diagnostic Bioprobes s.r.l (Italy) 9. Fast-track diagnostics Ltd. (Luxembourg) 10. Fortress Diagnostics Limited (Ireland) 11. Mikrogen GmBH (Germany) 12. MP Biomedicals, LLC. (California) 13. Primerdesign Ltd. (United Kingdom) 14. PerkinElmer, Inc. (United States) 15. ELITechGroup (France) 16. Diagnostic Automation/Cortez Diagnostics, Inc., (California) 17. ORGENTEC Diagnostika (Germany) 18. EUROIMMUN Medizinische Labordiagnostika AG. (Germany) 19. Abbott Laboratories (United States) 20. Siemens Ag, (Germany) FAQs: 1. What is the major growth driver for the Hepatitis E Diagnostic Tests market? Ans. The high prevalence rate of hepatitits E is expected to be the major driver for the Hepatitis E Diagnostic Tests market. 2. What is the major restraint for the Hepatitis E Diagnostic Tests market growth? Ans. The lack of skilled professionals are expected to be the major restraining factor for the Hepatitis E Diagnostic Tests market growth. 3. Which region is expected to lead the global Hepatitis E Diagnostic Tests market during the forecast period? Ans. The Asia-Pacific market is expected to lead the global Hepatitis E Diagnostic Tests market during the forecast period due to high prevalence rate of hepatitis E in the region. 4. What is the projected market size & growth rate of the Hepatitis E Diagnostic Tests Market? Ans. The Hepatitis E Diagnostic Tests Market size was valued at USD 137.48 Million in 2022 and the total Hepatitis E Diagnostic Tests revenue is expected to grow at a CAGR of 3.8% from 2023 to 2029, reaching nearly USD 178.49 Million. 5. What segments are covered in the Hepatitis E Diagnostic Tests Market report? Ans. The segments covered in the Hepatitis E Diagnostic Tests market report are Test kit Type, End-user, Test Type and Region.
1. Hepatitis E Diagnostic Tests Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Hepatitis E Diagnostic Tests Market: Dynamics 2.1. Hepatitis E Diagnostic Tests Market Trends by Region 2.1.1. North America Hepatitis E Diagnostic Tests Market Trends 2.1.2. Europe Hepatitis E Diagnostic Tests Market Trends 2.1.3. Asia Pacific Hepatitis E Diagnostic Tests Market Trends 2.1.4. Middle East and Africa Hepatitis E Diagnostic Tests Market Trends 2.1.5. South America Hepatitis E Diagnostic Tests Market Trends 2.2. Hepatitis E Diagnostic Tests Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Hepatitis E Diagnostic Tests Market Drivers 2.2.1.2. North America Hepatitis E Diagnostic Tests Market Restraints 2.2.1.3. North America Hepatitis E Diagnostic Tests Market Opportunities 2.2.1.4. North America Hepatitis E Diagnostic Tests Market Challenges 2.2.2. Europe 2.2.2.1. Europe Hepatitis E Diagnostic Tests Market Drivers 2.2.2.2. Europe Hepatitis E Diagnostic Tests Market Restraints 2.2.2.3. Europe Hepatitis E Diagnostic Tests Market Opportunities 2.2.2.4. Europe Hepatitis E Diagnostic Tests Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Hepatitis E Diagnostic Tests Market Drivers 2.2.3.2. Asia Pacific Hepatitis E Diagnostic Tests Market Restraints 2.2.3.3. Asia Pacific Hepatitis E Diagnostic Tests Market Opportunities 2.2.3.4. Asia Pacific Hepatitis E Diagnostic Tests Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Hepatitis E Diagnostic Tests Market Drivers 2.2.4.2. Middle East and Africa Hepatitis E Diagnostic Tests Market Restraints 2.2.4.3. Middle East and Africa Hepatitis E Diagnostic Tests Market Opportunities 2.2.4.4. Middle East and Africa Hepatitis E Diagnostic Tests Market Challenges 2.2.5. South America 2.2.5.1. South America Hepatitis E Diagnostic Tests Market Drivers 2.2.5.2. South America Hepatitis E Diagnostic Tests Market Restraints 2.2.5.3. South America Hepatitis E Diagnostic Tests Market Opportunities 2.2.5.4. South America Hepatitis E Diagnostic Tests Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Hepatitis E Diagnostic Tests Industry 2.8. Analysis of Government Schemes and Initiatives For Hepatitis E Diagnostic Tests Industry 2.9. Hepatitis E Diagnostic Tests Market Trade Analysis 2.10. The Global Pandemic Impact on Hepatitis E Diagnostic Tests Market 3. Hepatitis E Diagnostic Tests Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2022-2029 3.1. Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 3.1.1. ELISA HEV IgM Test kits 3.1.2. ELISA HEV IgG Test kits 3.1.3. RT-PCR Test kits 3.1.4. Other 3.2. Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 3.2.1. Hospitals 3.2.2. Research Centers 3.2.3. Diagnostic Laboratories 3.2.4. Point of Care 3.2.5. Other 3.3. Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 3.3.1. Blood Tests 3.3.2. Imaging Test 3.3.3. Liver Biopsy 3.4. Hepatitis E Diagnostic Tests Market Size and Forecast, by Region (2022-2029) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Hepatitis E Diagnostic Tests Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 4.1. North America Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 4.1.1. ELISA HEV IgM Test kits 4.1.2. ELISA HEV IgG Test kits 4.1.3. RT-PCR Test kits 4.1.4. Other 4.2. North America Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 4.2.1. Hospitals 4.2.2. Research Centers 4.2.3. Diagnostic Laboratories 4.2.4. Point of Care 4.2.5. Other 4.3. North America Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 4.3.1. Blood Tests 4.3.2. Imaging Test 4.3.3. Liver Biopsy 4.4. North America Hepatitis E Diagnostic Tests Market Size and Forecast, by Country (2022-2029) 4.4.1. United States 4.4.1.1. United States Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 4.4.1.1.1. ELISA HEV IgM Test kits 4.4.1.1.2. ELISA HEV IgG Test kits 4.4.1.1.3. RT-PCR Test kits 4.4.1.1.4. Other 4.4.1.2. United States Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 4.4.1.2.1. Hospitals 4.4.1.2.2. Research Centers 4.4.1.2.3. Diagnostic Laboratories 4.4.1.2.4. Point of Care 4.4.1.2.5. Other 4.4.1.3. United States Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 4.4.1.3.1. Blood Tests 4.4.1.3.2. Imaging Test 4.4.1.3.3. Liver Biopsy 4.4.2. Canada 4.4.2.1. Canada Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 4.4.2.1.1. ELISA HEV IgM Test kits 4.4.2.1.2. ELISA HEV IgG Test kits 4.4.2.1.3. RT-PCR Test kits 4.4.2.1.4. Other 4.4.2.2. Canada Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 4.4.2.2.1. Hospitals 4.4.2.2.2. Research Centers 4.4.2.2.3. Diagnostic Laboratories 4.4.2.2.4. Point of Care 4.4.2.2.5. Other 4.4.2.3. Canada Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 4.4.2.3.1. Blood Tests 4.4.2.3.2. Imaging Test 4.4.2.3.3. Liver Biopsy 4.4.3. Mexico 4.4.3.1. Mexico Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 4.4.3.1.1. ELISA HEV IgM Test kits 4.4.3.1.2. ELISA HEV IgG Test kits 4.4.3.1.3. RT-PCR Test kits 4.4.3.1.4. Other 4.4.3.2. Mexico Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 4.4.3.2.1. Hospitals 4.4.3.2.2. Research Centers 4.4.3.2.3. Diagnostic Laboratories 4.4.3.2.4. Point of Care 4.4.3.2.5. Other 4.4.3.3. Mexico Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 4.4.3.3.1. Blood Tests 4.4.3.3.2. Imaging Test 4.4.3.3.3. Liver Biopsy 5. Europe Hepatitis E Diagnostic Tests Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 5.1. Europe Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.2. Europe Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.3. Europe Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 5.4. Europe Hepatitis E Diagnostic Tests Market Size and Forecast, by Country (2022-2029) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.1.2. United Kingdom Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.1.3. United Kingdom Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type(2022-2029) 5.4.2. France 5.4.2.1. France Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.2.2. France Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.2.3. France Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type(2022-2029) 5.4.3. Germany 5.4.3.1. Germany Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.3.2. Germany Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.3.3. Germany Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 5.4.4. Italy 5.4.4.1. Italy Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.4.2. Italy Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.4.3. Italy Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type(2022-2029) 5.4.5. Spain 5.4.5.1. Spain Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.5.2. Spain Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.5.3. Spain Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 5.4.6. Sweden 5.4.6.1. Sweden Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.6.2. Sweden Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.6.3. Sweden Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 5.4.7. Austria 5.4.7.1. Austria Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.7.2. Austria Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.7.3. Austria Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 5.4.8.2. Rest of Europe Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 5.4.8.3. Rest of Europe Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6. Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 6.1. Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.2. Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.3. Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4. Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast, by Country (2022-2029) 6.4.1. China 6.4.1.1. China Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.1.2. China Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.1.3. China Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.2. S Korea 6.4.2.1. S Korea Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.2.2. S Korea Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.2.3. S Korea Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.3. Japan 6.4.3.1. Japan Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.3.2. Japan Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.3.3. Japan Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.4. India 6.4.4.1. India Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.4.2. India Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.4.3. India Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.5. Australia 6.4.5.1. Australia Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.5.2. Australia Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.5.3. Australia Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.6. Indonesia 6.4.6.1. Indonesia Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.6.2. Indonesia Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.6.3. Indonesia Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.7. Malaysia 6.4.7.1. Malaysia Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.7.2. Malaysia Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.7.3. Malaysia Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.8. Vietnam 6.4.8.1. Vietnam Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.8.2. Vietnam Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.8.3. Vietnam Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type(2022-2029) 6.4.9. Taiwan 6.4.9.1. Taiwan Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.9.2. Taiwan Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.9.3. Taiwan Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 6.4.10.2. Rest of Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 6.4.10.3. Rest of Asia Pacific Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 7. Middle East and Africa Hepatitis E Diagnostic Tests Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 7.1. Middle East and Africa Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 7.2. Middle East and Africa Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 7.3. Middle East and Africa Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 7.4. Middle East and Africa Hepatitis E Diagnostic Tests Market Size and Forecast, by Country (2022-2029) 7.4.1. South Africa 7.4.1.1. South Africa Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 7.4.1.2. South Africa Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 7.4.1.3. South Africa Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 7.4.2. GCC 7.4.2.1. GCC Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 7.4.2.2. GCC Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 7.4.2.3. GCC Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 7.4.3. Nigeria 7.4.3.1. Nigeria Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 7.4.3.2. Nigeria Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 7.4.3.3. Nigeria Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 7.4.4.2. Rest of ME&A Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 7.4.4.3. Rest of ME&A Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 8. South America Hepatitis E Diagnostic Tests Market Size and Forecast by Segmentation (by Value in USD Million) 2022-2029 8.1. South America Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 8.2. South America Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 8.3. South America Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type(2022-2029) 8.4. South America Hepatitis E Diagnostic Tests Market Size and Forecast, by Country (2022-2029) 8.4.1. Brazil 8.4.1.1. Brazil Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 8.4.1.2. Brazil Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 8.4.1.3. Brazil Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 8.4.2. Argentina 8.4.2.1. Argentina Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 8.4.2.2. Argentina Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 8.4.2.3. Argentina Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Kit Type (2022-2029) 8.4.3.2. Rest Of South America Hepatitis E Diagnostic Tests Market Size and Forecast, by End-user (2022-2029) 8.4.3.3. Rest Of South America Hepatitis E Diagnostic Tests Market Size and Forecast, by Test Type (2022-2029) 9. Global Hepatitis E Diagnostic Tests Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Hepatitis E Diagnostic Tests Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Chemeurope (EU) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Roche Holding AG (Switzerland) 10.3. Fortress Diagnostics (United Kingdom) 10.4. Altona Diagnostics GmbH (Germany) 10.5. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (China) 10.6. Biokit S.A. (Spain) 10.7. F. Hoffmann-La Roche Ltd. (Switzerland) 10.8. Dia.Pro - Diagnostic Bioprobes s.r.l (Italy) 10.9. Fast-track diagnostics Ltd. (Luxembourg) 10.10. Fortress Diagnostics Limited (Ireland) 10.11. Mikrogen GmBH (Germany) 10.12. MP Biomedicals, LLC. (California) 10.13. Primerdesign Ltd. (United Kingdom) 10.14. PerkinElmer, Inc. (United States) 10.15. ELITechGroup (France) 10.16. Diagnostic Automation/Cortez Diagnostics, Inc., (California) 10.17. ORGENTEC Diagnostika (Germany) 10.18. EUROIMMUN Medizinische Labordiagnostika AG. (Germany) 10.19. Abbott Laboratories (United States) 10.20. Siemens Ag, (Germany) 11. Key Findings 12. Industry Recommendations 13. Hepatitis E Diagnostic Tests Market: Research Methodology 14. Terms and Glossary